Anika Therapeutics (AKP.F) Q2 2025 Earnings

May 9Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.23
-0.1
0.03
0.16

Details

Expected EPS
-0.0799677
Actual EPS
-0.0533118
Surprise EPS
0.03
Surprise Percent
+33.33%

Description

⁨Anika Therapeutics⁩ (⁦AKP.F⁩) has reported earnings of ⁦-0.0533118⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts